Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01750086 · ClinicalTrials.gov registry record · Phase 4
Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 27
- Enrollment target
NCT01750086: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT01750086 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 27 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01750086, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 27 participants
- Enrollment target
Study Summary
The aim of the study is to assess the relative antiresorptive properties of 2 osteoporosis medications when combined with teriparatide.
Primary Outcome
The primary outcome was the between-group difference in the teriparatide-induced change in serum c-telopeptide from baseline to week 8.
Interventions
- DRUG Denosumab Injection
- DRUG Teriparatide 40-mcg subcutaneous injection
- DRUG Alendronate Oral Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2013-01 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
What the finished NCT01750086 record still lists
NCT01750086 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Denosumab Injection is the first listed.
NCT01750086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01750086 about?
NCT01750086 is a clinical study titled "Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption". The aim of the study is to assess the relative antiresorptive properties of 2 osteoporosis medications when combined with teriparatide.
What is the current status of trial NCT01750086?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 27 participants. The study started on 2013-01. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01750086?
The interventions under investigation include: Denosumab Injection (DRUG), Teriparatide 40-mcg subcutaneous injection (DRUG), Alendronate Oral Tablet (DRUG).
Who is sponsoring clinical trial NCT01750086?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01750086's enrollment target sits among peer trials
27 1651st of 2000 higher than 346 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia